Dr. Nader Makki, MD

Dr. Makki practices at Dignity Health St. Joseph's Hospital and Medical Center in Phoenix, Arizona, part of CommonSpirit Health.

Dr. Makki's NPI, 1306127808, was assigned on August 29, 2011. Dr. Makki holds Arizona license 55739.

Dr. Makki's primary practice is Dignity Health St. Joseph's Hospital and Medical Center, at 350 West Thomas Road, Phoenix, AZ 85013 in Maricopa County. The practice phone is (602) 406-8225.

Dr. Makki's primary practice is Dignity Health St. Joseph's Hospital and Medical Center in Phoenix, Arizona, part of CommonSpirit Health. Dr. Makki is also affiliated with Tucson Medical Center. The medical group on file is St. Joseph's Faculty Physicians. Dmand AI also links Dr. Makki to 3 more hospitals, 3 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Makki practices, 8 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Makki's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Makki's licenses on file in 3 states: Arizona, Iowa and Ohio.

CMS data shows 5,711 Medicare services from Dr. Makki across 43 procedure codes in 2024, for 1,109 Medicare patients. Medicare paid $502,890 for them.

CMS counts 1,109 Medicare patients who saw Dr. Makki in 2024. The largest group is 65 to 74, with 450 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Makki's median patient age at 69, with 51% women.

In 2024, Dr. Makki wrote 5,941 Medicare Part D claims for 1,082 patients. 85% of them were for generic drugs. CMS names the drug for 5,624 of them, across 55 drugs with 11 or more claims each, at $947,293 in total drug cost. In 2023, CMS named 4,940 claims across 59 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Makki for performance year 2024, reported as part of a group. Dr. Makki accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Makki as offering telehealth. CMS counts 50 procedures of coronary angioplasty and stenting by Dr. Makki, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 23 papers to Dr. Makki, published from 2013 to 2019. 2013 was the busiest year, with 5. The most frequent topics are Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis and Aortic Valve. Dr. Makki has published most often in J Invasive Cardiol. Dr. Makki's most frequent co-authors are Scott Matthew Lilly, MD, Juan Crestanello, MD and Peter John Kaboli, MD.

Dmand AI links Dr. Makki to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Angina, Stable, Heart Failure and Mitral Valve Insufficiency. Open Payments lists research payments to Dr. Makki that name 1 trial.

CMS Open Payments shows 186 general payments to Dr. Makki from 24 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 49% of the total. Abbott Laboratories paid the most, $1,968. It also lists 1 research payment totaling $63 in 2023, naming 1 clinical trial.